{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:17:12Z","timestamp":1780377432560,"version":"3.54.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13014-018-0961-x","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T07:29:22Z","timestamp":1517556562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Fitting NTCP models to bladder doses and acute urinary symptoms during post-prostatectomy radiotherapy"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9066-5123","authenticated-orcid":false,"given":"Panayiotis","family":"Mavroidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Pearlstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Dooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Saripalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva K.","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Z.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,2]]},"reference":[{"key":"961_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.radonc.2009.08.004","volume":"93","author":"C Fiorino","year":"2009","unstructured":"Fiorino C, Valdagni R, Rancati T, et al. Dose\u2013volume effects for normal tissues in external radiotherapy: pelvis. Radiother Oncol. 2009;93:153\u201367.","journal-title":"Radiother Oncol"},{"key":"961_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.eururo.2011.09.027","volume":"61","author":"L Budaus","year":"2012","unstructured":"Budaus L, Bolla M, Bossi A, et al. Functional outcome and complications following radiation therapy for prostate cancer: a critical analysis of the literature. Eur Urol. 2012;61:112\u201327.","journal-title":"Eur Urol"},{"key":"961_CR3","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1016\/j.ijrobp.2009.01.043","volume":"76","author":"AN Viswanathan","year":"2010","unstructured":"Viswanathan AN, Yorke ED, Marks LB, et al. Radiation dose volume effects of the urinary bladder. Int J Radiat Oncol Biol. 2010;76:S123\u20139.","journal-title":"Int J Radiat Oncol Biol"},{"key":"961_CR4","doi-asserted-by":"publisher","first-page":"S130","DOI":"10.1016\/j.ijrobp.2009.04.094","volume":"76","author":"M Roach III","year":"2010","unstructured":"Roach M III, Nam J, Gagliardi G, et al. Radiation dose\u2013volume effects of the penile bulb. Int J Radiat Oncol Biol Phys. 2010;76:S130\u20134.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"961_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","volume":"46","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:765\u201381.","journal-title":"Eur J Cancer"},{"key":"961_CR6","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1097\/00005650-200110000-00009","volume":"39","author":"JA Clark","year":"2001","unstructured":"Clark JA, Talcott JA. Symptom indexes to assess outcomes of treatment for early prostate cancer. Med Care. 2001;39:1118\u201330.","journal-title":"Med Care"},{"key":"961_CR7","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/jama.2017.1652","volume":"317","author":"RC Chen","year":"2017","unstructured":"Chen RC, Basak R, Meyer AM, et al. Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer. JAMA. 2017;317:1141\u201350.","journal-title":"JAMA"},{"key":"961_CR8","doi-asserted-by":"publisher","first-page":"5058","DOI":"10.1200\/JCO.2007.11.7275","volume":"25","author":"LI Wagner","year":"2007","unstructured":"Wagner LI, Wenzel L, Shaw E, et al. Patient-reported outcomes in phase II cancer clinical trials: lessons learned and future directions. J Clin Oncol. 2007;25:5058\u201362.","journal-title":"J Clin Oncol"},{"key":"961_CR9","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/cncr.24963","volume":"116","author":"RC Chen","year":"2010","unstructured":"Chen RC, Mamon HJ, Chen YH, et al. Patient-reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer. Cancer. 2010;116:1879\u201386.","journal-title":"Cancer"},{"key":"961_CR10","first-page":"119","volume":"5","author":"LT Flores","year":"2012","unstructured":"Flores LT, Bennett AV, Law EB, et al. Patient-reported outcomes vs. clinician symptom reporting during Chemoradiation for rectal cancer. Gastrointest Cancer Res. 2012;5:119\u201324.","journal-title":"Gastrointest Cancer Res"},{"key":"961_CR11","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1111\/j.1464-410X.2012.11117.x","volume":"110","author":"RC Chen","year":"2012","unstructured":"Chen RC, Zhang Y, Chen MH, et al. Patient-reported quality of life during radiation treatment for localized prostate cancer: results from a prospective phase II trial. BJU Int. 2012;110:1690\u20135.","journal-title":"BJU Int"},{"key":"961_CR12","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.juro.2006.06.067","volume":"176","author":"J Talcott","year":"2006","unstructured":"Talcott J, Clark J, Manola J, et al. Bringing prostate cancer quality of life research back to the bedside: translating numbers into a format that patients can understand. J Urol. 2006;176:1558\u201363.","journal-title":"J Urol"},{"key":"961_CR13","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1016\/j.ejca.2009.07.009","volume":"45","author":"O Matzinger","year":"2009","unstructured":"Matzinger O, Duclos F, van den Bergh A, et al. Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991. Eur J Cancer. 2009;45:2825\u201334.","journal-title":"Eur J Cancer"},{"key":"961_CR14","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.radonc.2017.06.020","volume":"124","author":"P Mavroidis","year":"2017","unstructured":"Mavroidis P, Price A, Fried D, et al. Dose-volume toxicity modeling for de-intensified chemo-radiation therapy for HPV-positive oropharynx cancer. Radiother Oncol. 2017;124:240\u20137.","journal-title":"Radiother Oncol"},{"key":"961_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S1053-4296(05)80045-1","volume":"2","author":"JF Fowler","year":"1992","unstructured":"Fowler JF. Brief summary of radiobiological principles in fractionated radiotherapy. Semin Radiat Oncol. 1992;2:16\u201321.","journal-title":"Semin Radiat Oncol"},{"key":"961_CR16","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.ijrobp.2008.11.039","volume":"73","author":"JF Fowler","year":"2009","unstructured":"Fowler JF. Sensitivity analysis of parameters in linear-quadratic radiobiologic modeling. Int J Radiat Oncol Biol Phys. 2009;73:1532\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"961_CR17","first-page":"1100","volume":"26","author":"A Niemierko","year":"1999","unstructured":"Niemierko A. A generalized concept of equivalent uniform dose. Med Phys. 1999;26:1100.","journal-title":"Med Phys"},{"key":"961_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0360-3016(98)00196-5","volume":"42","author":"S Kwa","year":"1998","unstructured":"Kwa S, Lebesque J, Theuws JC, et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys. 1998;42:1\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"961_CR19","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S0360-3016(02)03986-X","volume":"55","author":"Y Seppenwoolde","year":"2003","unstructured":"Seppenwoolde Y, Lebesque J, Jaeger K, et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Int J Radiat Oncol Biol Phys. 2003;55:724\u201335.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"961_CR20","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/0360-3016(94)00471-4","volume":"31","author":"A Jackson","year":"1995","unstructured":"Jackson A, Ten Haken RK, Robertson JM, et al. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys. 1995;31:883\u201391.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"961_CR21","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1080\/028418699432950","volume":"38","author":"BK Lind","year":"1999","unstructured":"Lind BK, Mavroidis P, Hy\u00f6dynmaa S, et al. Optimization of the dose level for a given treatment plan to maximize the complication free tumor cure. Acta Oncol. 1999;38:787\u201398.","journal-title":"Acta Oncol"},{"key":"961_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/09553009214552071","volume":"62","author":"P K\u00e4llman","year":"1992","unstructured":"K\u00e4llman P, \u00c5gren AK, Brahme A. Tumor and normal tissue responses to fractionated non uniform dose delivery. Int J Radiat Biol. 1992;62:249\u201362.","journal-title":"Int J Radiat Biol"},{"key":"961_CR23","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/02841860310012833","volume":"42","author":"P Mavroidis","year":"2003","unstructured":"Mavroidis P, Laurell G, Kraepelien T, et al. Determination and clinical verification of dose-response parameters for esophageal stricture from head and neck radiotherapy. Acta Oncol. 2003;42:865\u201381.","journal-title":"Acta Oncol"},{"key":"961_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0360-3016(80)90042-5","volume":"6","author":"DF Herring","year":"1980","unstructured":"Herring DF. Methods for extracting dose-response curves from radiation therapy data, I: a unified approach. Int J Radiat Oncol Biol Phys. 1980;6:225\u201332.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"961_CR25","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","volume":"19","author":"H Akaike","year":"1974","unstructured":"Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control. 1974;19:716\u201323.","journal-title":"IEEE Trans Autom Control"},{"key":"961_CR26","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1200\/JCO.2016.70.0229","volume":"35","author":"K Wang","year":"2017","unstructured":"Wang K, Eblan MJ, Deal AM, et al. Cardiac toxicity after radiotherapy for stage III non-small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy. J Clin Oncol. 2017;35:1387\u201394.","journal-title":"J Clin Oncol"},{"key":"961_CR27","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ijrobp.2004.04.017","volume":"60","author":"G De Meerleer","year":"2004","unstructured":"De Meerleer G, Vakaet L, Meersschout S, et al. Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients. Int J Radiat Oncol Biol Phys. 2004;60:777\u201387.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"961_CR28","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.clon.2010.01.005","volume":"22","author":"T Guerrero Urbano","year":"2010","unstructured":"Guerrero Urbano T, Khoo V, Staffurth J, et al. Intensity-modulated radiotherapy allows escalation of the radiation dose to the pelvic lymph nodes in patients with locally advanced prostate cancer: preliminary results of a phase I dose escalation study. Clin Oncol. 2010;22:236\u201344.","journal-title":"Clin Oncol"},{"key":"961_CR29","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00066-012-0169-1","volume":"188","author":"AC Muller","year":"2012","unstructured":"Muller AC, Lutjens J, Alber M, et al. Toxicity and outcome of pelvic IMRT for node-positive prostate cancer. Strahlenther Onkol. 2012;188:982\u20139.","journal-title":"Strahlenther Onkol"},{"key":"961_CR30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s00066-003-1029-9","volume":"179","author":"G Goldner","year":"2003","unstructured":"Goldner G, Wachter-Gerstner N, Wachter S, et al. Acute side effects during 3-D-planned conformal radiotherapy of prostate cancer. Differences between patient's self-reported questionnaire and the corresponding doctor's report. Strahlenther Onkol. 2003;179:320\u20137.","journal-title":"Strahlenther Onkol"},{"key":"961_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1023\/A:1026458604826","volume":"6","author":"RJ Stephens","year":"1997","unstructured":"Stephens RJ, Hopwood P, Girling DJ, et al. Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings? Qual Life Res. 1997;6:225\u201336.","journal-title":"Qual Life Res"},{"key":"961_CR32","doi-asserted-by":"publisher","first-page":"5049","DOI":"10.1200\/JCO.2007.14.5888","volume":"25","author":"SB Clauser","year":"2007","unstructured":"Clauser SB, Ganz PA, Lipscomb J, et al. Patient-reported outcomes assessment in cancer trials: evaluating and enhancing the payoff to decision making. J Clin Oncol. 2007;25:5049\u201350.","journal-title":"J Clin Oncol"},{"key":"961_CR33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.radonc.2014.02.006","volume":"111","author":"V Carillo","year":"2014","unstructured":"Carillo V, Cozzarini C, Rancati T, et al. Relationships between bladder dose\u2013volume\/surface histograms and acute urinary toxicity after radiotherapy for prostate cancer. Radiother Oncol. 2014;111:100\u20135.","journal-title":"Radiother Oncol"},{"key":"961_CR34","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/1754-9485.12043","volume":"57","author":"B Chua","year":"2013","unstructured":"Chua B, Min M, Wood M, et al. Implementation of an image guided intensity-modulated protocol for post-prostatectomy radiotherapy: planning data and acute toxicity outcomes. J Med Imaging Radiat Oncol. 2013;57:482\u20139.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"961_CR35","doi-asserted-by":"publisher","first-page":"e657","DOI":"10.1016\/j.ijrobp.2011.09.006","volume":"82","author":"S Myrehaug","year":"2012","unstructured":"Myrehaug S, Chan G, Craig T, et al. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2012;82:e657\u201362.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"961_CR36","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.ijrobp.2011.07.019","volume":"83","author":"D Vesprini","year":"2012","unstructured":"Vesprini D, Catton C, Jacks L, et al. Inverse relationship between biochemical outcome and acute toxicity after image-guided radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2012;83:608\u201316.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"961_CR37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1748-717X-6-145","volume":"6","author":"S Gill","year":"2011","unstructured":"Gill S, Thomas J, Fox C, et al. Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy. Radiat Oncol. 2011;6:145.","journal-title":"Radiat Oncol"},{"key":"961_CR38","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.urolonc.2005.02.005","volume":"23","author":"HK Tsai","year":"2005","unstructured":"Tsai HK, Manola J, Abner A, et al. Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy. Urol Oncol. 2005;23:230\u20137.","journal-title":"Urol Oncol"},{"key":"961_CR39","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.2147\/OTT.S116508","volume":"9","author":"J Zhu","year":"2016","unstructured":"Zhu J, Simon A, Haigron P, et al. The benefit of using bladder sub-volume equivalent uniform dose constraints in prostate intensity-modulated radiotherapy planning. Onco Targets Ther. 2016;9:7537\u201344.","journal-title":"Onco Targets Ther"},{"key":"961_CR40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejmp.2017.07.003","volume":"40","author":"P Mavroidis","year":"2017","unstructured":"Mavroidis P, Komisopoulos G, Buckey C, et al. Radiobiological evaluation of prostate cancer IMRT and conformal-RT plans using different treatment protocols. Phys Med. 2017;40:33\u201341.","journal-title":"Phys Med"},{"key":"961_CR41","unstructured":"\u00c5gren AK: Quantification of the response of heterogeneous tumors and organized normal tissues to fractionated radiotherapy. Ph.D. Thesis. Stockholm: Stockholm University, 1995."},{"key":"961_CR42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0360-3016(91)90172-Z","volume":"21","author":"C Burman","year":"1991","unstructured":"Burman C, Kutcher GJ, Emami B, et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 1991;21:123\u201335.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"961_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","volume":"21","author":"B Emami","year":"1991","unstructured":"Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109\u201322.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"961_CR44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.radonc.2016.01.013","volume":"119","author":"M Thor","year":"2016","unstructured":"Thor M, Olsson C, Oh JH, et al. Urinary bladder dose-response relationships for patient-reported genitourinary morbidity domains following prostate cancer radiotherapy. Radiother Oncol. 2016;119:117\u201322.","journal-title":"Radiother Oncol"},{"key":"961_CR45","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.radonc.2015.07.048","volume":"116","author":"C Cozzarini","year":"2015","unstructured":"Cozzarini C, Rancati T, Carillo V, et al. Multi-variable models predicting specific patient-reported acute urinary symptoms after radiotherapy for prostate cancer: results of a cohort study. Radiother Oncol. 2015;116:185\u201391.","journal-title":"Radiother Oncol"},{"key":"961_CR46","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.radonc.2015.11.036","volume":"118","author":"F Palorini","year":"2016","unstructured":"Palorini F, Rancati T, Cozzarini C, et al. Multi-variable models of large international prostate symptom score worsening at the end of therapy in prostate cancer radiotherapy. Radiother Oncol. 2016;118:92\u20138.","journal-title":"Radiother Oncol"},{"key":"961_CR47","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1200\/JCO.2015.64.2702","volume":"34","author":"HI Scher","year":"2016","unstructured":"Scher HI, Morris MJ, Stadler WM, et al. Trial design and objectives for castration-resistant prostate cancer: updated recommendations from the prostate cancer clinical trials working group 3. J Clin Oncol. 2016;34:1402\u201318.","journal-title":"J Clin Oncol"},{"key":"961_CR48","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.radonc.2012.03.004","volume":"105","author":"I Beetz","year":"2012","unstructured":"Beetz I, Schilstra C, Van der Schaaf A, et al. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors. Radiother Oncol. 2012;105:101\u20136.","journal-title":"Radiother Oncol"},{"key":"961_CR49","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.radonc.2011.11.006","volume":"105","author":"I Beetz","year":"2012","unstructured":"Beetz I, Schilstra C, Van Luijk P, et al. External validation of three dimensional conformal radiotherapy based NTCP models for patient-rated xerostomia and sticky saliva among patients treated with intensity modulated radiotherapy. Radiother Oncol. 2012;105:94\u2013100.","journal-title":"Radiother Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-0961-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T19:32:21Z","timestamp":1549049541000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-018-0961-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,2]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["961"],"URL":"https:\/\/doi.org\/10.1186\/s13014-018-0961-x","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,2]]},"assertion":[{"value":"25 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There is an IRB approval for this study by the Ethics committee of the University of North Carolina. Additionally, this is retrospective analysis so no patient consent required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"17"}}